| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |